Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JH.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CK.1.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.34.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.2.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JK.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.31NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.13.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BN.1.3.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XCF.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XCCNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FK.1.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.21.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FP.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.92NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.42NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.35.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GE.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HE.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.33NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FY.4.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.99NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HW.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.4.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FE.1.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HA.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.16.14NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.5.1.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.28NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.20.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.110NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.86.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GN.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.8.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HB.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.10.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.89NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GR.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.16.21NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.568NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
P.1.13 (Gamma)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.372NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.634NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.37.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.630NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.360NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HF.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.31NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HG.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used